So this paper is about how you can improve cancer outcomes now in this paper we focus specifically on using and collecting data better in order to do this and what we say in this paper is actually data can be better collected in use throughout the whole treatment pathway so from prevention and early diagnosis all the way through to.
Recovery the data that the NHS collects is one of its greatest assets but at the moment the NHS isn’t.
Always transferring that data into insight and really using that.
Insight to drive improvements in care.
What we send is paper it’s that we need to be doing this in cancer and if we can turn data into insight this means that doctors will be able to make better decisions about patients care but also will be able to do a lot more around preventing cancer diagnosed being diagnosed in the first place and also helping those who are developing cancer and giving them some earlier diagnosis and there’s been a lot of research that shows that if your cancer is diagnosed much earlier on in the treatment pathway.
Then you’ll have a much greater chance of survival so in breast cancer for example if your cancer is diagnosed at stage one you’ll have almost a 100% chance of surviving up to five years whereas if your cancer is.
Diagnosed in stage four your chances drop down to 30 so the good news.
Is we already have the infrastructure there to do this the cancer dashboard was set up by public health England a few years ago and what we say.
In this paper is this dashboard needs to be improved and extended so that becomes a single point of access for all.
Data on cancer outcomes and it should not only include data on cancer outcomes but also look at pulling on datasets across the whole cancer pathway so data around treatment data around patient experience and data on a patient’s medical history one example that we we actually talk about in the paper is the 100,000 genome project and how in the future.
The cancer dashboard could be linked with data from that so that we can actually look at how a patient’s genetic profile might affect their outcomes and and what treatments they both respond to.
Now obviously all of this is going to be dependent on having a secure system in the NHS for storing this data and for patients to give their consent for the NHS to link this data in the first place so as a patient this model of using data better all mean that I will have a far more personalized and integrated care experience so.
If for example I am identified by data as someone.
More at risk of developing a cancer I could sit down and have a one-to-one.
Appointment with my GP and they would present prevent present me with different options how I might say improve on some of my health.
Behaviors so the amount advise me to change my diet or join an exercise class now if I was against someone.
Who was at risk of developing cancer data might be used to send me personalized information encouraging me to go to screening and when I was a screening good quality data could be paired with artificial.
Intelligence in order to improve the accuracy of my screening tests now post diagnosis if I did develop cancer this data could be used so that I could receive.